XML 30 R19.htm IDEA: XBRL DOCUMENT
v3.22.1

Net Loss Per Share (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2022
Net Loss Per Share [Abstract] |
Schedule of Anti-dilutive securities not included in diluted net loss per share calculation | ​
​ | ​ | ​ | ​ | ​
​ | ​ | As of March 31,
​ |  | 2022 |  | 2021
Convertible preferred stock (as converted) | ​ | — |  | 15,907,629
Common stock options outstanding | ​ | 4,262,702 |  | 3,113,640
Unvested restricted stock units | ​ | 279,500 | ​ | —
Total | ​ | 4,542,202 |  | 19,021,269

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration